Precision medicine: from pharmacogenomics to pharmacoproteomics

Abstract

Disease progression and drug response may vary significantly from patient to patient. Fortunately, the rapid development of high-throughput ‘omics’ technologies has allowed for the identification of potential biomarkers that may aid in the understanding of the heterogeneities in disease development and treatment outcomes. However, mechanistic gaps remain… (More)
DOI: 10.1186/s12014-016-9127-8

Topics

1 Figure or Table

Slides referencing similar topics